Xingxing Xu

1.8k total citations
33 papers, 934 citations indexed

About

Xingxing Xu is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Cell Biology. According to data from OpenAlex, Xingxing Xu has authored 33 papers receiving a total of 934 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 11 papers in Cellular and Molecular Neuroscience and 9 papers in Cell Biology. Recurrent topics in Xingxing Xu's work include Neuroscience and Neuropharmacology Research (7 papers), Hippo pathway signaling and YAP/TAZ (7 papers) and Glioma Diagnosis and Treatment (4 papers). Xingxing Xu is often cited by papers focused on Neuroscience and Neuropharmacology Research (7 papers), Hippo pathway signaling and YAP/TAZ (7 papers) and Glioma Diagnosis and Treatment (4 papers). Xingxing Xu collaborates with scholars based in China, United States and United Kingdom. Xingxing Xu's co-authors include Jianhong Luo, Kangcheng Ruan, Weiguo Zou, Guoliang Xu, Xiaobo Gao, Yonghui Tao, Lei Zhang, Xufang Li, Feng Wang and Ronggui Hu and has published in prestigious journals such as International Journal of Cancer, Experimental Cell Research and Cell Research.

In The Last Decade

Xingxing Xu

32 papers receiving 927 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xingxing Xu China 15 595 143 120 116 101 33 934
Mei-Yao Lin United States 12 695 1.2× 219 1.5× 147 1.2× 68 0.6× 35 0.3× 14 1.2k
John P. Grady United Kingdom 22 1.1k 1.8× 208 1.5× 72 0.6× 105 0.9× 39 0.4× 51 1.4k
Yoshitsugu Saishin Japan 22 749 1.3× 112 0.8× 66 0.6× 115 1.0× 46 0.5× 56 1.8k
Friederike Schröter Germany 11 785 1.3× 121 0.8× 107 0.9× 68 0.6× 63 0.6× 16 1.3k
Shuang Feng China 15 651 1.1× 72 0.5× 86 0.7× 200 1.7× 155 1.5× 36 974
Pierre Mazot France 13 581 1.0× 122 0.9× 95 0.8× 87 0.8× 31 0.3× 14 827
Ginez A. González United Kingdom 9 368 0.6× 103 0.7× 150 1.3× 57 0.5× 134 1.3× 11 765
Carmen Streicher Austria 12 651 1.1× 162 1.1× 104 0.9× 202 1.7× 78 0.8× 17 1.0k
Jimmy Huynh United States 16 872 1.5× 102 0.7× 63 0.5× 207 1.8× 177 1.8× 25 1.3k
Stephen Sikkink United Kingdom 15 407 0.7× 56 0.4× 83 0.7× 88 0.8× 96 1.0× 20 892

Countries citing papers authored by Xingxing Xu

Since Specialization
Citations

This map shows the geographic impact of Xingxing Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xingxing Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xingxing Xu more than expected).

Fields of papers citing papers by Xingxing Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xingxing Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xingxing Xu. The network helps show where Xingxing Xu may publish in the future.

Co-authorship network of co-authors of Xingxing Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Xingxing Xu. A scholar is included among the top collaborators of Xingxing Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xingxing Xu. Xingxing Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Shaohong, et al.. (2023). Bufei Yishen Formula Inhibits the Cell Senescence in COPD by Up-Regulating the ZNF263 and Klotho Expression. International Journal of COPD. Volume 18. 533–539. 2 indexed citations
3.
Xu, Xingxing, et al.. (2023). Study on the Influence of Coil Placement on Pulsed Eddy Current Testing. Journal of Physics Conference Series. 2418(1). 12013–12013. 1 indexed citations
4.
Zhang, Jingjing, Xingxing Xu, Jia Li, et al.. (2022). Astrocytic SARM1 promotes neuroinflammation and axonal demyelination in experimental autoimmune encephalomyelitis through inhibiting GDNF signaling. Cell Death and Disease. 13(9). 759–759. 22 indexed citations
5.
Zhang, Jingjing, Xingxing Xu, Huitao Liu, et al.. (2021). Astrocytic YAP prevents the demyelination through promoting expression of cholesterol synthesis genes in experimental autoimmune encephalomyelitis. Cell Death and Disease. 12(10). 907–907. 22 indexed citations
6.
Liu, Huitao, Jingjing Zhang, Xingxing Xu, et al.. (2021). SARM1 promotes neuroinflammation and inhibits neural regeneration after spinal cord injury through NF-κB signaling. Theranostics. 11(9). 4187–4206. 111 indexed citations
7.
Liu, Xiao‐Rong, Xingxing Xu, Tingting Ye, et al.. (2021). GRIN2A Variants Associated With Idiopathic Generalized Epilepsies. Frontiers in Molecular Neuroscience. 14. 720984–720984. 16 indexed citations
8.
Yang, Danlu, Xingxing Xu, Xin Wang, et al.. (2021). β-elemene promotes the senescence of glioma cells through regulating YAP-CDK6 signaling.. PubMed. 11(2). 370–388. 10 indexed citations
10.
Chen, Yun, Lin Xu, Yun Yang, et al.. (2020). Screening for bacterial enzymes synthesizing GPR119 agonist in cAMP-responsive cells. Acta Biochimica et Biophysica Sinica. 53(1). 121–123. 3 indexed citations
11.
Deng, Xiangyang, Xingxing Xu, Dongdong Lin, et al.. (2020). Real-World Impact of Surgical Excision on Overall Survival in Primary Central Nervous System Lymphoma. Frontiers in Oncology. 10. 131–131. 24 indexed citations
12.
Deng, Xiangyang, Dongdong Lin, Bo Chen, et al.. (2019). Development and Validation of an IDH1-Associated Immune Prognostic Signature for Diffuse Lower-Grade Glioma. Frontiers in Oncology. 9. 1310–1310. 29 indexed citations
13.
Deng, Xiangyang, Dongdong Lin, Lisheng Yu, et al.. (2018). The role of postoperative radiotherapy in pediatric patients with grade II intracranial ependymomas: a population-based, propensity score-matched study. Cancer Management and Research. Volume 10. 5515–5524. 4 indexed citations
14.
Wang, Ying, Xingxing Xu, Xinping Zhou, et al.. (2018). NMDA receptors inhibit axonal outgrowth by inactivating Akt and activating GSK-3β via calcineurin in cultured immature hippocampal neurons. Experimental Cell Research. 371(2). 389–398. 13 indexed citations
15.
Xu, Xingxing & Jianhong Luo. (2017). Mutations of N-Methyl-D-Aspartate Receptor Subunits in Epilepsy. Neuroscience Bulletin. 34(3). 549–565. 50 indexed citations
16.
Xu, Xingxing, Xiao‐Rong Liu, Yi‐Wu Shi, et al.. (2017). Functional Investigation of a GRIN2A Variant Associated with Rolandic Epilepsy. Neuroscience Bulletin. 34(2). 237–246. 13 indexed citations
17.
Peng, Lin, Qian Yang, Xingxing Xu, et al.. (2017). Huntingtin-Interacting Protein 1-Related Protein Plays a Critical Role in Dendritic Development and Excitatory Synapse Formation in Hippocampal Neurons. Frontiers in Molecular Neuroscience. 10. 186–186. 14 indexed citations
18.
Xu, Xingxing, Yonghui Tao, Xiaobo Gao, et al.. (2016). A CRISPR-based approach for targeted DNA demethylation. Cell Discovery. 2(1). 16009–16009. 291 indexed citations
19.
Zhang, Xiaomin, Bin Zhang, Qian Yang, et al.. (2015). Activity-induced synaptic delivery of the GluN2A-containing NMDA receptor is dependent on endoplasmic reticulum chaperone Bip and involved in fear memory. Cell Research. 25(7). 818–836. 26 indexed citations
20.
Chang, Wenjun, Liye Ma, Liping Lin, et al.. (2009). Identification of novel hub genes associated with liver metastasis of gastric cancer. International Journal of Cancer. 125(12). 2844–2853. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026